NKp30 Antibodies

Santa Cruz Biotechnology features a diverse variety of NKp30 monoclonal antibodies for advanced research in immunology and cell biology. NKp30 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NKp30, also known as natural killer cell p30, is a crucial activating receptor expressed on natural killer (NK) cells and plays a significant role in the immune response against tumors and virally infected cells. By recognizing specific ligands on target cells, NKp30 contributes to the regulation of immune surveillance and the elimination of aberrant cells, making it an important focus in cancer immunotherapy and infectious disease research. Understanding the function of NKp30 is essential for developing strategies to enhance immune responses and improve therapeutic outcomes. Researchers can investigate NK cell activation pathways and their role in immune system regulation through detailed analysis of NKp30 expression and function. NKp30 research has revealed important insights into NK cell biology and their potential applications in cancer treatment. Exploring NKp30 signaling mechanisms has enhanced our understanding of immune system activation and regulation. Santa Cruz Biotechnology monoclonal antibodies for NKp30 support researchers worldwide in advancing immunology research and developing innovative therapeutic strategies.